The urgent need to redefine quality of life in patients with low-grade glioma

For a long time, oncological considerations prevailed in patients with low-grade glioma (LGG), the main goal being to increase the progression-free survival and overall survival. Thanks to a paradigmatic shift based on early and maximal surgical resection(s) with (possibly delayed) adjuvant medical therapies, overall survival is now beyond 20 years. Functional considerations, however, received less attention. In most studies, only standard neurological examinations were carried out to search for motor and/or language deterioration, optionally with a rough evaluation of major cognitive dysfunctions (e.g. using Mini Mental State Examination) which could have a substantial negative impact on autonomy. Yet, patients with LGG are usually young and enjoy an active life at the time of diagnosis, and they have currently a life expectancy about one generation: they should thereby have the capacities to make long-lasting projects. To this end, there is an urgent need to redefine the concept of quality of life in these patients who will live with a chronic tumoral disease for many years/decades, by integrating more subtle criteria. It currently seems difficult to be content with the sole maintenance of basic neurological functions critical for survival but not enabling to build a more fulfilling life. Here, the purpose is to take into consideration higher-order cognitive (including metacognitive), behavioral, psychological, sexual, familial, socio-professional, and creative aspects. Assessment of QoL should be refined according to the wishes of each human being living with a LGG, based on his/her own conception of what should be his/her long-term future despite an incurable disease.

Authors

Institutions

Publication Details

Journal
ESMO rare cancers.
Published
2025-02-28
DOI
https://doi.org/10.1016/j.esmorc.2025.100003
Citations
1
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
1.63
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The urgent need to redefine quality of life in patients with low-grade glioma

Hugues Duffau
1 citations
ESMO rare cancers.
Glioma Diagnosis and Treatment
1.63
article

The urgent need to redefine quality of life in patients with low-grade glioma

Hugues Duffau
article en
1 citations

Abstract

For a long time, oncological considerations prevailed in patients with low-grade glioma (LGG), the main goal being to increase the progression-free survival and overall survival. Thanks to a paradigmatic shift based on early and maximal surgical resection(s) with (possibly delayed) adjuvant medical therapies, overall survival is now beyond 20 years. Functional considerations, however, received less attention. In most studies, only standard neurological examinations were carried out to search for motor and/or language deterioration, optionally with a rough evaluation of major cognitive dysfunctions (e.g. using Mini Mental State Examination) which could have a substantial negative impact on autonomy. Yet, patients with LGG are usually young and enjoy an active life at the time of diagnosis, and they have currently a life expectancy about one generation: they should thereby have the capacities to make long-lasting projects. To this end, there is an urgent need to redefine the concept of quality of life in these patients who will live with a chronic tumoral disease for many years/decades, by integrating more subtle criteria. It currently seems difficult to be content with the sole maintenance of basic neurological functions critical for survival but not enabling to build a more fulfilling life. Here, the purpose is to take into consideration higher-order cognitive (including metacognitive), behavioral, psychological, sexual, familial, socio-professional, and creative aspects. Assessment of QoL should be refined according to the wishes of each human being living with a LGG, based on his/her own conception of what should be his/her long-term future despite an incurable disease.

ESMO rare cancers.Vol. 1
Université de Montpellier (FR), Hôpital Gui de Chauliac (FR), Fonctionnement et Conduite des Systèmes de Culture Tropicaux et Méditerranéens (FR)
Openalex Percentile: Top 20%
Glioma Diagnosis and Treatment
1.63
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The urgent need to redefine quality of life in patients with low-grade glioma — Hugues Duffau · ESMO rare cancers. (2025) | TGRS Research Map | TGRS